Re: Farmas USA
Tengo curiosidad por saber que va ha hacer esta, Columbia Laboratories (CBRX), porque algo va ha hacer. Divergencia alcista en el A/D, Bollinger comprimido, volumen secándose... técnicamente yo diría que está a punto de explotar hacia arriba, pero es que los fundamentales de la compañía no me gustan un pelo. De Octubre:
Before noon, shares of Columbia Laboratories (CBRX) have already exchanged hands at more than ten times average volume, and the stock is down 40%. The blow comes after Columbia and partner Watson Pharmaceuticals (WPI) announced that CBRX`s lead candidate, Prochieve, was denied an appeal for further FDA review and approval. Prospects for Columbia Laboratories look bleak without its single developmental product, and the future of the company falls to its line of Women`s Health products or a major strategic maneuver.
CBRX